ScholarIQanswers from OpenAlex & ORCID
George Wilding
ResearcherPublications, citations & collaboration network
George Wilding is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does George Wilding have?
ScholarIQindexed works
George Wilding has 394 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does George Wilding have?
ScholarIQcitation count
George Wilding has 33,412 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of George Wilding?
ScholarIQh-index
George Wilding has an h-index of 81 in OpenAlex.
What is the i10-index of George Wilding?
ScholarIQi10-index
George Wilding has an i10-index of 251 in OpenAlex.
What is the OpenAlex record for George Wilding?
ScholarIQopenalex
The OpenAlex for George Wilding is on the source record.
What are the most-cited papers on George Wilding?
ScholarIQmost cited works
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
Glenn J. Bubley, Michael A. Carducci, William L. Dahut, Nancy A. Dawson, Danai Daliani, Mario A. Eisenberger, William D. Figg, Boris Freidlin, Susan Halabi, Gary R. Hudes, Maha Hussain, Richard Kaplan, Charles E. Myers, William Oh, Daniel P. Petrylak, Eddie Reed, Bruce J. Roth, Oliver Sartor, Howard I. Scher, Jonathan W. Simons, Vickie Sinibaldi, Eric J. Small, Matthew R. Smith, Donald L. Trump, Robin T. Vollmer, George Wilding
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson